GLO1, the major enzyme detoxifying methylglyoxal (MGO) and the subsequent advanced glycation end products of AGEs, protects vessels from atherosclerosis by inhibiting endothelial dysfunction and smooth muscle proliferation [48]. The gene discussed is GLO1; the disease is endothelial dysfunction.